Literature DB >> 23912941

Protein WISDOM: a workbench for in silico de novo design of biomolecules.

James Smadbeck1, Meghan B Peterson, George A Khoury, Martin S Taylor, Christodoulos A Floudas.   

Abstract

The aim of de novo protein design is to find the amino acid sequences that will fold into a desired 3-dimensional structure with improvements in specific properties, such as binding affinity, agonist or antagonist behavior, or stability, relative to the native sequence. Protein design lies at the center of current advances drug design and discovery. Not only does protein design provide predictions for potentially useful drug targets, but it also enhances our understanding of the protein folding process and protein-protein interactions. Experimental methods such as directed evolution have shown success in protein design. However, such methods are restricted by the limited sequence space that can be searched tractably. In contrast, computational design strategies allow for the screening of a much larger set of sequences covering a wide variety of properties and functionality. We have developed a range of computational de novo protein design methods capable of tackling several important areas of protein design. These include the design of monomeric proteins for increased stability and complexes for increased binding affinity. To disseminate these methods for broader use we present Protein WISDOM (http://www.proteinwisdom.org), a tool that provides automated methods for a variety of protein design problems. Structural templates are submitted to initialize the design process. The first stage of design is an optimization sequence selection stage that aims at improving stability through minimization of potential energy in the sequence space. Selected sequences are then run through a fold specificity stage and a binding affinity stage. A rank-ordered list of the sequences for each step of the process, along with relevant designed structures, provides the user with a comprehensive quantitative assessment of the design. Here we provide the details of each design method, as well as several notable experimental successes attained through the use of the methods.

Mesh:

Substances:

Year:  2013        PMID: 23912941      PMCID: PMC3846368          DOI: 10.3791/50476

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  43 in total

1.  Ab initio prediction of helical segments in polypeptides.

Authors:  J L Klepeis; C A Floudas
Journal:  J Comput Chem       Date:  2002-01-30       Impact factor: 3.376

2.  Native protein sequences are close to optimal for their structures.

Authors:  B Kuhlman; D Baker
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

3.  Protein-protein docking with simultaneous optimization of rigid-body displacement and side-chain conformations.

Authors:  Jeffrey J Gray; Stewart Moughon; Chu Wang; Ora Schueler-Furman; Brian Kuhlman; Carol A Rohl; David Baker
Journal:  J Mol Biol       Date:  2003-08-01       Impact factor: 5.469

4.  Automated NMR structure calculation with CYANA.

Authors:  Peter Güntert
Journal:  Methods Mol Biol       Date:  2004

5.  Toward full-sequence de novo protein design with flexible templates for human beta-defensin-2.

Authors:  Ho Ki Fung; Christodoulos A Floudas; Martin S Taylor; Li Zhang; Dimitrios Morikis
Journal:  Biophys J       Date:  2007-09-07       Impact factor: 4.033

6.  A new generation of potent complement inhibitors of the Compstatin family.

Authors:  Aliana López de Victoria; Ronald D Gorham; Meghan L Bellows-Peterson; Jun Ling; David D Lo; Christodoulos A Floudas; Dimitrios Morikis
Journal:  Chem Biol Drug Des       Date:  2011-04-26       Impact factor: 2.817

7.  Tertiary templates for proteins. Use of packing criteria in the enumeration of allowed sequences for different structural classes.

Authors:  J W Ponder; F M Richards
Journal:  J Mol Biol       Date:  1987-02-20       Impact factor: 5.469

8.  Automated design of the surface positions of protein helices.

Authors:  B I Dahiyat; D B Gordon; S L Mayo
Journal:  Protein Sci       Date:  1997-06       Impact factor: 6.725

9.  Torsion angle dynamics for NMR structure calculation with the new program DYANA.

Authors:  P Güntert; C Mumenthaler; K Wüthrich
Journal:  J Mol Biol       Date:  1997-10-17       Impact factor: 5.469

10.  Contact prediction for beta and alpha-beta proteins using integer linear optimization and its impact on the first principles 3D structure prediction method ASTRO-FOLD.

Authors:  R Rajgaria; Y Wei; C A Floudas
Journal:  Proteins       Date:  2010-06
View more
  11 in total

Review 1.  The coming of age of de novo protein design.

Authors:  Po-Ssu Huang; Scott E Boyken; David Baker
Journal:  Nature       Date:  2016-09-15       Impact factor: 49.962

Review 2.  Protein Design: From the Aspect of Water Solubility and Stability.

Authors:  Rui Qing; Shilei Hao; Eva Smorodina; David Jin; Arthur Zalevsky; Shuguang Zhang
Journal:  Chem Rev       Date:  2022-08-03       Impact factor: 72.087

Review 3.  Protein folding and de novo protein design for biotechnological applications.

Authors:  George A Khoury; James Smadbeck; Chris A Kieslich; Christodoulos A Floudas
Journal:  Trends Biotechnol       Date:  2013-11-19       Impact factor: 19.536

4.  Molecular recognition of CCR5 by an HIV-1 gp120 V3 loop.

Authors:  Phanourios Tamamis; Christodoulos A Floudas
Journal:  PLoS One       Date:  2014-04-24       Impact factor: 3.240

5.  New compstatin peptides containing N-terminal extensions and non-natural amino acids exhibit potent complement inhibition and improved solubility characteristics.

Authors:  Ronald D Gorham; David L Forest; George A Khoury; James Smadbeck; Consuelo N Beecher; Evangeline D Healy; Phanourios Tamamis; Georgios Archontis; Cynthia K Larive; Christodoulos A Floudas; Monte J Radeke; Lincoln V Johnson; Dimitrios Morikis
Journal:  J Med Chem       Date:  2014-12-29       Impact factor: 7.446

6.  De novo design and experimental characterization of ultrashort self-associating peptides.

Authors:  James Smadbeck; Kiat Hwa Chan; George A Khoury; Bo Xue; Robert C Robinson; Charlotte A E Hauser; Christodoulos A Floudas
Journal:  PLoS Comput Biol       Date:  2014-07-10       Impact factor: 4.475

7.  Elucidating a key component of cancer metastasis: CXCL12 (SDF-1α) binding to CXCR4.

Authors:  Phanourios Tamamis; Christodoulos A Floudas
Journal:  J Chem Inf Model       Date:  2014-04-08       Impact factor: 4.956

8.  Forcefield_NCAA: ab initio charge parameters to aid in the discovery and design of therapeutic proteins and peptides with unnatural amino acids and their application to complement inhibitors of the compstatin family.

Authors:  George A Khoury; James Smadbeck; Phanourios Tamamis; Andrew C Vandris; Chris A Kieslich; Christodoulos A Floudas
Journal:  ACS Synth Biol       Date:  2014-01-14       Impact factor: 5.110

9.  Elucidating a key anti-HIV-1 and cancer-associated axis: the structure of CCL5 (Rantes) in complex with CCR5.

Authors:  Phanourios Tamamis; Christodoulos A Floudas
Journal:  Sci Rep       Date:  2014-06-26       Impact factor: 4.379

Review 10.  A review of computational tools for design and reconstruction of metabolic pathways.

Authors:  Lin Wang; Satyakam Dash; Chiam Yu Ng; Costas D Maranas
Journal:  Synth Syst Biotechnol       Date:  2017-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.